Scarica l'app Stockscreener
208.25
0.82%
1.7416
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$206.51
Aprire:
$206.76
Volume 24 ore:
1.21M
Relative Volume:
0.56
Capitalizzazione di mercato:
$59.35B
Reddito:
$21.84B
Utile/perdita netta:
$1.68B
Rapporto P/E:
35.72
EPS:
5.8293
Flusso di cassa netto:
$2.67B
1 W Prestazione:
+2.33%
1M Prestazione:
+1.39%
6M Prestazione:
+20.77%
1 anno Prestazione:
-8.36%
Intervallo 1D:
$204.90
$208.41
Intervallo di 1 settimana:
$201.19
$213.08
Portata 52W:
$162.29
$235.34
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
208.32 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
489.39 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
RMD
Resmed Inc
|
271.06 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.32 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.52 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2025-09-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
A Look at Becton, Dickinson's Upcoming Earnings Report - Benzinga
How To Earn $500 A Month From Becton Dickinson Stock Ahead Of Q1 Earnings - Benzinga
3 Best Dividend Kings for 2026 - Investing.com
Piper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX) - Finviz
Becton, Dickinson and Company (NYSE:BDX) Now Covered by Citigroup - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Strengthening Families & Communities LLC Buys 13,086 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Citi Upgrades Becton Dickinson & Co(BDX.US) to Buy Rating, Raises Target Price to $233 - 富途牛牛
Becton, Dickinson and Company (BDX): A Bull Case Theory - Finviz
Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Growth in the Medical Instruments Sector - DirectorsTalk Interviews
Mirae Asset Global Investments Co. Ltd. Boosts Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (NYSE:BDX) Will Pay A Dividend Of $1.05 - simplywall.st
Becton Dickinson's (NYSE:BDX) Dividend Will Be $1.05 - Yahoo Finance UK
Becton, Dickinson and Company $BDX Shares Acquired by TD Waterhouse Canada Inc. - MarketBeat
Becton, Dickinson and Company (BDX) Announces Executive Severanc - GuruFocus
Everett Harris & Co. CA Sells 7,344 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Reshapes Portfolio With Waters Deal And Recycling Progress - Yahoo Finance UK
Becton Dickinson director Scott Bertram sells $159,593 in stock - MSN
Does The Recent Share Price Slide Make Becton Dickinson (BDX) Look Interesting Again? - simplywall.st
BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care - Finviz
Recycling possible for PS petri dishes, other lab equipment - Plastics News
Becton Dickinson Hit With Lawsuit Over Catheter-Insertion Patent - Bloomberg Law News
The Analyst Verdict: Becton Dickinson In The Eyes Of 7 Experts - Benzinga
Becton, Dickinson and Company (NYSE:BDX) EVP Sells $15,204.75 in Stock - MarketBeat
Feld Michael, evp at Becton Dickinson, sells $15k in stock By Investing.com - Investing.com Australia
BD, Waters set completion date for $17.5B biosciences and diagnostics merger - MedTech Dive
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld Michael, evp at Becton Dickinson, sells $15k in stock - Investing.com India
Becton, Dickinson and Company $BDX Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $205 - 富途牛牛
How Investors Are Reacting To Becton Dickinson (BDX) Dividend Hike, Buyback Plan And AI-Driven Upgrades - simplywall.st
Becton Dickinson & Co To Go Ex-Dividend On March 10th, 2026 With 1.05 USD Dividend Per Share - 富途牛牛
BECTON, DICKINSON Q1 2026 Earnings Preview: Recent $BDX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
$17.5B BD Spinoff Nears Completion - Medical Device and Diagnostic industry
BD Biosciences & Diagnostic Solutions Spin-Off to Combine With Waters in Reverse Morris Trust - citybiz
BD sets date for spin-off of Biosciences & Diagnostics Solutions business to Waters - MassDevice
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business - Financial Times
(01/27/26) Top Picks 2026: Becton, Dickinson & Co. (BDX) - moneyshow.com
Becton, Dickinson and Company $BDX Holdings Lifted by Sector Gamma AS - MarketBeat
Becton, Dickinson and Company $BDX Shares Purchased by Commerzbank Aktiengesellschaft FI - MarketBeat
BDX and WST Stocks Fall Amid Novo Nordisk's Oral Wegovy Success - GuruFocus
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation - Finviz
Becton, Dickinson and Co (NYSE:BDX) Shows High Technical and Setup Ratings for Potential Breakout - Chartmill
BICO company Biosero launches GoSimple™, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) - marketscreener.com
BD and Ypsomed Expand Partnership to Target Growing Biologics Market - Yahoo Finance
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $210 - 富途资讯
Universal Beteiligungs und Servicegesellschaft mbH Acquires 8,561 Shares of Becton, Dickinson and Company $BDX - MarketBeat
BD and Ypsomed partner to develop 5.5 mL prefillable syringe By Investing.com - Investing.com Nigeria
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market - Finviz
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System - Yahoo Finance
BD and Ypsomed partner to develop 5.5 mL prefillable syringe - Investing.com
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):